We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

World's First AI Solution for Flagging PE Receives FDA Approval

By MedImaging International staff writers
Posted on 01 Jun 2019
An artificial intelligence (AI) solution for flagging pulmonary embolism (PE) has been granted clearance by the US FDA. The solution has been developed by Aidoc (Tel Aviv, Israel), a provider of AI solutions for radiologists, and works with radiologists to flag and triage PE cases in chest CTs.

Aidoc's solutions analyze medical images directly after the patient is scanned and notify the radiologists of cases with suspected findings to assist with prioritization of time-sensitive and potentially life-threatening cases. Aidoc cuts the time from scan to diagnosis for some patients from hours to less than five minutes, speeding up treatment and improving prognosis. Aidoc’s latest PE solution adds to its expanding suite of AI-based workflow orchestration solutions. PE diagnosis can be highly challenging due to its variable and non-specific presentation, making AI-driven workflow triage especially beneficial.

Image: The FDA has approved a new AI solution for finding and triaging PEs in CT scans (Photo courtesy of Aidoc).
Image: The FDA has approved a new AI solution for finding and triaging PEs in CT scans (Photo courtesy of Aidoc).

"What really excites us about this clearance is that it paves the way towards scalable product expansion," said Elad Walach, Aidoc co-founder and CEO. "We strive to provide our customers with comprehensive end-to-end solutions and have put a lot of effort in developing a scalable AI platform. It took us 18 months to get our first FDA clearance, 6 for the second one, and we have 8 more packages in active clinical trials, I'm excited about what will come next. I can only extend my utmost gratitude to the FDA for having open communication channels and working together with us on clearing many solutions in parallel."

Related Links:
Aidoc


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Needle Guide
Ultra-Pro II
Digital Radiography Acquisition Software
VXvue with PureImpact
Compact C-Arm with FPD
Arcovis DRF-C R21

Latest Industry News News

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

International Societies Suggest Key Considerations for AI Radiology Tools